Back to Search
MICHAEL LANIER, MD
MD
Diagnostic Radiology Physician
NPI: 1508386632IndividualAccepts Medicare
Specialties, Licenses & Credentials
Diagnostic Radiology PhysicianPrimary
Radiology — Diagnostic Radiology
Code: 2085R0202X
2022011837(MO)
CMS Specialties
PrimaryDIAGNOSTIC RADIOLOGY
Education
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
Class of 2017
Research & Publications (20)
Regulation of fibroblast mitochondrial 27-hydroxycholesterol production by active plasma membrane cholesterol.
PMID 19401598·J Lipid Res·2009
7-preclinical
N-[6-amino-2-(heteroaryl)pyrimidin-4-yl]acetamides as A2A receptor antagonists with improved drug like properties and in vivo efficacy.
PMID 19140664·J Med Chem·2009
7-preclinical
Lead optimization of 4-acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines as A2A adenosine receptor antagonists for the treatment of Parkinson's disease.
PMID 18947224·J Med Chem·2008
7-preclinical
2,6-Diaryl-4-acylaminopyrimidines as potent and selective adenosine A(2A) antagonists with improved solubility and metabolic stability.
PMID 18835161·Bioorg Med Chem Lett·2008
8-other
Niemann-Pick C1 protects against atherosclerosis in mice via regulation of macrophage intracellular cholesterol trafficking.
PMID 18483620·J Clin Invest·2008
7-preclinical
Scale-dependence of Cope's rule in body size evolution of Paleozoic brachiopods.
PMID 18367673·Proc Natl Acad Sci U S A·2008
7-preclinical
Synthesis of N-pyrimidinyl-2-phenoxyacetamides as adenosine A2A receptor antagonists.
PMID 18329269·Bioorg Med Chem Lett·2008
7-preclinical
2-Amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists: 2. Reduction of hERG activity, observed species selectivity, and structure-activity relationships.
PMID 18307293·J Med Chem·2008
7-preclinical
2-Amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists: 1. Structure-activity relationships and optimization of heterocyclic substituents.
PMID 18307292·J Med Chem·2008
7-preclinical
2,6-Diaryl-4-phenacylaminopyrimidines as potent and selective adenosine A(2A) antagonists with reduced hERG liability.
PMID 18249540·Bioorg Med Chem Lett·2008
8-other
Identification of novel, water-soluble, 2-amino-N-pyrimidin-4-yl acetamides as A2A receptor antagonists with in vivo efficacy.
PMID 18189346·J Med Chem·2008
7-preclinical
Effectors of rapid homeostatic responses of endoplasmic reticulum cholesterol and 3-hydroxy-3-methylglutaryl-CoA reductase.
PMID 18024962·J Biol Chem·2008
7-preclinical
Selection, synthesis, and structure-activity relationship of tetrahydropyrido[4,3-d]pyrimidine-2,4-diones as human GnRH receptor antagonists.
PMID 17561404·Bioorg Med Chem·2007
8-other
Identification of 2-(4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-3-yl)-ethylamine derivatives as novel GnRH receptor antagonists.
PMID 17521908·Bioorg Med Chem Lett·2007
7-preclinical
Design, synthesis, and SAR studies on a series of 2-pyridinylpiperazines as potent antagonists of the melanocortin-4 receptor.
PMID 16697187·Bioorg Med Chem Lett·2006
8-other
Expressed needs and behavioral risk factors of HIV-positive inmates.
PMID 16260483·Int J Offender Ther Comp Criminol·2005
8-other
Design and synthesis of tricyclic imidazo[4,5-b]pyridin-2-ones as corticotropin-releasing factor-1 antagonists.
PMID 16078829·J Med Chem·2005
7-preclinical
A potent and selective nonpeptide antagonist of the melanocortin-4 receptor induces food intake in satiated mice.
PMID 15863313·Bioorg Med Chem Lett·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 510 S KINGSHIGHWAY BLVD, DEPT RADIOLOGY
SAINT LOUIS, MO 63110 - Phone
- (314) 362-7200
Quick Facts
- NPI
- 1508386632
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 9
- Publications
- 20
Are you this provider?
Claim Your Profile